Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DMEPOS codes reviewed

This article was originally published in The Gray Sheet

Executive Summary

CMS has made preliminary decisions regarding 112 requests for changes to HCPCS codes for durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) in 2007. The agency will hear public comments on the decisions in a series of meetings from April 25 to May 5. During a Program Advisory & Oversight Committee meeting in September, DMEPOS stakeholders stressed the need to update and expand HCPCS codes for their products before competitive bidding is instituted in 2007. Without the update, suppliers under the system may hamper beneficiary access by providing the lowest quality products within each code, they warned (1"The Gray Sheet" Oct. 3, 2005, p. 15)...

You may also be interested in...

Diabetes Products Should Be Exempt From Competitive Bidding – Panel

Supplier and manufacturer stakeholders are urging CMS to exclude blood glucose testing products from the impending DMEPOS competitive bidding program

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza

The latest drug development news and highlights from our US FDA Performance Tracker.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts